CC BY-NC-ND 4.0 · Endosc Int Open 2023; 11(09): E873-E879
DOI: 10.1055/a-2153-7016
Original article

Costs of purchase, maintenance, microbiological control, and reprocessing of a reusable duodenoscope

1   Pharmacy, Euro-Pharmat, Hôtel Dieu, Toulouse, France
,
Fanny Durand
2   Pôle Thoraco-Abdomen, CHU Limoges, Limoges, France (Ringgold ID: RIN36715)
,
Joseph Hajjar
3   Medical Officer of Health and Epidemiologist, Honorary Hospital Practitioner, Pau, France
,
Emma Le Dinh
4   Pharmacy, Clinique Pasteur, Toulouse, France (Ringgold ID: RIN54918)
,
Vanessa Metz
5   Pharmacy, Hopital Europeen Marseille, Marseille, France (Ringgold ID: RIN614971)
,
Bertrand Napoleon
6   Endoscopy Unit, Centre Chirurgical Lyon Mermoz, Lyon, France (Ringgold ID: RIN89686)
,
Céline Plessis
7   Pharmacy, CHU de Bordeaux, Bordeaux, France (Ringgold ID: RIN36836)
,
Frédéric Prat
8   Endoscopy, Hopital Beaujon, Clichy, France (Ringgold ID: RIN55100)
,
9   Pôle Digestif, Hôpital de L'Archet 2, Nice, France
,
Isabelle Durand-Zaleski
10   Public Health, Hopital Henri Mondor, Creteil, France (Ringgold ID: RIN55471)
,
Thierry Ponchon
11   Hepatogastroenterology, Edouard Herriot Hospital, Lyon, France
› Author Affiliations
Supported by: Boston Scientific Corporation

Abstract

Background and study aims The costs of reusable endoscope reprocessing have been evaluated, yet external validity of the findings remains challenging. The aim of this study was to assess the costs of purchase, maintenance, microbiological control, and reprocessing of a reusable duodenoscope per endoscopic retrograde cholangiopancreatography (ERCP) in France. Study findings exclude the costs of infection, downtime due to breakdown, reprocessing single-use material disposal, and device disposal, all of which should also be considered.

Materials and methods The study encompassed both observational and theoretical approaches. Observational data were collected in four hospitals, from December 2019 to December 2020, with an ad hoc survey, based on 2016 and 2018 national guidelines for duodenoscope reprocessing. Costs were modeled, using the same guidelines, assuming a mean workload of 223 ERCP/duodenoscope/year.

Results The mean observed cost of purchase, maintenance, microbiological control, reprocessing (human resources and consumables), and overhead (additional 35%) with a reusable duodenoscope was €80.23 (standard deviation €3.77) per ERCP. The corresponding mean theoretical cost was €182.71 for manual reprocessing without endoscope drying cabinet (EDC), €191.36 for manual reprocessing with EDC, €235.25 for automated endoscope reprocessing (AER) without EDC, and €253.62 for AER with EDC.

Conclusions Because procedures, equipment, volume activity, number of duodenoscopes, human resources, and internal work organizations are hospital-dependent, observed costs varied between hospitals. Theoretical costs were higher than observed costs, showing that the theoretical approach is not sufficient. Hypotheses to explain the difference between the two approaches include failing to measure some costs in the survey and challenges in guideline implementation.

Supporting information



Publication History

Received: 20 December 2022

Accepted after revision: 21 July 2023

Article published online:
21 September 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany